Additionally, the aberrantly expression of HVEM, BTLA, and LIGHT has been studied in some autoimmune diseases, such as RA, T1DM, and SLE, and there was disease-specific difference in the outcomes (63, 72–75). This evidence concerns the gene TNFSF14 and rheumatoid arthritis.